Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Monte Rosa Therapeutics (GLUE) Asset Utilization Ratio: 2024-2025

Historic Asset Utilization Ratio for Monte Rosa Therapeutics (GLUE) over the last 1 years, with Sep 2025 value amounting to 0.44.

  • Monte Rosa Therapeutics' Asset Utilization Ratio was N/A to 0.44 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44, marking a year-over-year change of. This contributed to the annual value of 0.20 for FY2024, which is N/A change from last year.
  • Monte Rosa Therapeutics' Asset Utilization Ratio amounted to 0.44 in Q3 2025, which was down 6.30% from 0.47 recorded in Q2 2025.
  • Monte Rosa Therapeutics' 5-year Asset Utilization Ratio high stood at 0.47 for Q2 2025, and its period low was 0.20 during Q4 2024.
  • In the last 2 years, Monte Rosa Therapeutics' Asset Utilization Ratio had a median value of 0.41 in 2025 and averaged 0.38.